TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE D-

NCT07280065: REVEAL Study - Diagnostic Testing for PTSD Using the Senseye Diagnostic Tool

Sponsor: Senseye, Inc. · Phase: PHASE3 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 1900 pts

Competing Trials Overlap

6 Active Trials

Excess Burn Exposure

$15,086,080

Rescue Site Savings

+$9,947,384

Unlock Full NCT07280065 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07280065 Rescue Dossier →